Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

Gilead and Merck said their once-weekly pill to treat HIV resulted in a comparable level of viral suppression compared to a ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

The 5th HIV Research for Prevention Conference (HIVR4P 2024) held in Lima, Peru, marked a significant milestone in the global ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Finding out you have HIV can be scary and intimidating news, but so much has changed that now people can lead long and ...

ATLANTA — Thousands of people gathered in Atlanta on Saturday morning to help keep awareness for AIDS top of mind as ...

Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

The World Council of Churches has newly published a discussion document: Good News about HIV Treatment, Cure, and Healing: ...

Code Pharma, a pioneering pharmaceutical company headquartered in the Netherlands, is set to present groundbreaking findings from its clinical trials on GAMMORA, a drug aimed at treating HIV, at two ...